CytRx Corp.
(Other OTC/NBB : CYTR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
MDCOThe Medicines Co.
0.37%84.2120.1%$585.94m
AMRNAmarin Corp. Plc
2.93%22.451.7%$318.11m
VRXValeant Pharmaceuticals International, Inc.
0.52%29.1014.1%$171.23m
BHCBausch Health Cos., Inc.
0.52%29.100.0%$100.43m
JAZZJazz Pharmaceuticals Plc
0.92%149.462.3%$94.15m
SAGESAGE Therapeutics, Inc.
7.11%64.468.6%$93.27m
GWPHGW Pharmaceuticals Plc
-2.39%101.056.2%$88.36m
ICPTIntercept Pharmaceuticals, Inc.
-10.27%107.4816.9%$82.62m
PRGOPerrigo Co. Plc
0.97%52.316.8%$66.45m
AXSMAxsome Therapeutics, Inc.
5.07%45.432.0%$55.58m
HZNPHorizon Therapeutics Plc
1.16%32.236.6%$43.62m
ICLRICON plc
0.93%162.904.2%$42.90m
ENDPEndo International Plc
0.42%4.848.8%$34.41m
UTHRUnited Therapeutics Corp.
1.53%91.6114.3%$33.37m
MYOKMyoKardia, Inc.
0.46%67.432.1%$30.25m

Company Profile

CytRx Corp. is a biopharmaceutical research and development company, which engages in the discovery, research, and clinical development of novel anti-cancer drug candidates. It focuses on developing the Linker Activated Drug Release (LADR) technology platform, a discovery engine to help create a pipeline of anti-cancer molecules that will avoid unacceptable systemic toxicity while delivering highly potent agents directly to the tumor. The company was founded on February 28, 1985 and is headquartered in Los Angeles, CA.